Aiding AIDS: Hurdling the Obstacles to the Development of an Effective AIDS Vaccine
Open/View files
Date
2002
Author(s)
Greilsamer, Glenn J.
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Aiding AIDS: Hurdling the Obstacles to the Development of an Effective AIDS Vaccine (2002 Third Year Paper)
Abstract
This paper explores the various impediments to the development of a safe and effective AIDS vaccine, and offers suggestions to help overcome these obstacles. I begin by discussing the FDA approval process and the current state of AIDS vaccine development. I then consider the different scientific impediments to the development of a preventive vaccine. The next section addresses the logistical and ethical issues in the clinical testing of a vaccine. I discuss the ethical principles that should guide researchers, demonstrate the social harm that participation may cause volunteers, and suggest methods to resolve these ethical dilemmas. Finally, I discuss the economic impediments faced by manufacturers in the form of high costs, uncertain profit margins, and unpredictable liability. Using past legislative attempts at restructuring manufacturer incentives as models, I present recommendations to help encourage manufacturers to produce the safest and most effective vaccine they can, and make it available as quickly as possible.
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service
Collection